Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinomas

Human Pathology

Volumn 30, Issue 4, 1999, Pages 443-450

  Ogata, Riko ^a   Torimura, Takuji ^b   Kin, Motoaki ^b   Ueno, Takato ^b   Tateishi, Yukio ^b   Kuromatsu, Ryoko ^b   Shimauchi, Yoshihiro ^b   Sakamoto, Masaharu ^b   Tamaki, Seisyu ^b   Sata, Michio ^b   Tanikawa, Kyuichi ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Gelatin zymography; HCC; Immunohistochemistry; In situ hybridization; MMP 2; MT MMP

Indexed keywords

COLLAGENASE; GELATINASE A;

ADULT; AGED; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CELL CARCINOMA; MALE; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

EID: 13044305842     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90121-1     Document Type: Article

References (44)

1. Albelda SM: Biology of disease: Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 68:4-17, 1993
2. McCormick BA, Zetter BR: Adhesive interactions in angiogenesis and metastasis. Pharmacol Ther 53:239-260, 1992
3. Liotta LA: Tumor invasion and metastasis: Role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res 46:1-7, 1986
4. Nagase H, Okada Y: Proteinases and matrix degradation, in Kelly WN, Harris ED Jr, Ruddy S, et al (eds): Textbook of Rheumatology. Philadelphia, PA, Saunders, 1997, pp 323-341
5. Matrisiari LM: The matrix-degrading metalloproteinases. Bio Essays 14:455-463, 1992
6. Redale JP: Matrix turnover in fibrogenesis. Hepatogastroenterology 43:56-71, 1996
7. Springman EB, Angleton EL, Birkedahl-Hansen H, et al: Multiple modes of activation of latent human fibroblast collagenase: Evidence for the role of a cys-73 active site zinc complex in latency and a cysteine switch mechanism for activation. Proc Natl Acad Sci USA 87:364-368, 1990
8. Stetler-Stevenson W, Krutzch HC, Wacher M, et al: The activation of human type IV collagenase proenzyme: Sequence identification of the major conversion product following organomercurial activation. J Biol Chem 264:1353-1356, 1989
9. Kusukawa J, Sasaguri Y, Shima I, et al: Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. Am J Clin Pathol 99:18-23, 1993
10. Yamamoto M, Mohanam S, Sawaya R, et al: Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56:384-392, 1996
11. Nomura H, Sato H, Seiki M, et al: Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55:3263-3266, 1995
12. Brown PD, Bloxidge RE, Stuart NSA, et al: Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 85:574-578, 1993
13. Brown PD, Bloxidge RE, Anderson E, et al: Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis 11:183-189, 1993
14. Davis B, Waxman J, Wasan H, et al: Levels of matrix metalloproteinase in bladder cancer correlate with tumor grade and invasion. Cancer Res 53:5365-5369, 1993
15. Sato H, Takino T, Okada Y, et al: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65, 1994
16. Okada A, Belloq JP, Rouyer N, et al: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast and head and neck carcinomas. Natl Acad Sci U S A 92:2730-2734, 1995
17. Will H, Hinzmann B: cDNA sequence and mRNA distribution of a novel human matrix metalloproteinase with a potential transmembrane domain. Eur J Biochem 231:602-608, 1995
18. Takino T, Sato H, Shinagawa A, et al: Identification of the second membrane-type matrix metalloproteinase (MT-MMP2) gene from a human placenta cDNA library. J Biol Chem 270:23013-23020, 1995
19. Puente XS, Pendas AM, Llano E, et al: Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56:944-949, 1996
20. Gilles C, Polette M, PietteJ: High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 65:209-213, 1996
21. Tokuraku M, Sato H, Murakami S, et al: Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 64:355-359, 1995
22. Biscegli AM, Rustgi VK, Hoofnagle JH, et al: Hepatocellular carcinoma. Ann Intern Med 108:390-401, 1988
23. Oda T, Tsuda H, Scarpa A, et al: Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res 52:3674-3678, 1992
24. Arakawa M, Kage M, Sugihara S, et al: Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver: Observation in five cases. Gastroenterology 91:198-208, 1986
25. Liver Cancer Study Group of Japan: The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, February 26, 1992
26. Kenmochi K, Sugihara S, Kojiro M: Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC. Liver 7:18-26, 1987
27. Sugihara S, Nakashima O, Kojiro M, et al: The morphologic transition in hepatocellular carcinoma: A comparison of the individual histologic features disclosed by ultrasound-guided fine-needle biopsy with those of autopsy. Cancer 70:1488-1492, 1992
28. Edmondson HA, Steiner PE: Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 7:462-501, 1954
29. MacDonald RA: Primary carcinoma of the liver. Arch Intern Med 99:266-279, 1957
30. Wiler DL, Wood PA, Willett FM: Primary cancer of the liver. Ann Intern Med 20:453-485, 1944
31. Kojiro M, Sugihara S, Nakashima O: Pathomorphologic characteristics of early hepatocellular carcinoma. Gann Monograph on Cancer Research 38:29-37, 1991
32. Hsu SM, Raine L, Fanger II: Use of avidin-biotin-peroxidase complex (ABC) antibody (PAD) procedures. Histochem Cytochem 29:577-580, 1981
33. Osamura RY, Komatsu N, Watanabe K, et al: Immunohistochemical and immunocytochemical localization of r-melanocyte stimulating hormone (r-MSH)-like immunoreactivity in human and rat hypothalamus. Peptides 3:781-787, 1982
34. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activities in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102:196-202, 1980
35. Gilles C, Polette M, Seiki M, et al: Implication of collagen type 1-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab Invest 76:651-660, 1997
36. Pei D, Weiss SJ: Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 271:9135-9140, 1996
37. Sato H, Kinoshita T, Takino T, et al: Activation of a recombinant membrane-type 1-matrix metalloproteinase (MTI-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393:101-104, 1996
38. Hatsuzawa K, Hosaka M, Nakagawa T, et al: Structure and expression of mouse furin, a yeast Kex2-related protease: Lack of processing of coexpressed prorenin in GH4C1 cells. J Biol Chem 265:22075-22078, 1990
39. Lichte A, Kolkenbrock H, Tschesche H: The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MTI-MMP) induces activation of progrlatinase A and progrlatinase A complexed with TIMP-2. FEBS Lett 397:277-282, 1996
40. Strongin AY, Collier I, Bannikov G, et al: Mechanism of cell surface activation of 72kDa type IV collagenase. J Biol Chem 270:5331-5338, 1995
41. Nakatsukasa H, Ashida K, Higashi T, et al: Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas. Hepatology 24:82-88, 1996
42. Pulyaeva H, Bueno J, Polette M, et al: MTI-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metabol 15:111-120, 1997
43. Chen W-T, Lee C-C, Goldstein L, et al: Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy. Breast Cancer Res Treat 31:217-226, 1994
44. Arii S, Mise M, Harada T, et al: Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive otential. Hepatology 24:316-322, 1996